Durela: new extended-release tramadol productNew drug is for the management of moderate to moderately-severe pain in adults who require continuous treatment for several days or more. Learn how to optimize patient safety during NSAIDs treatmentAt the Primary Care Today pharmacy CE day, pharmacists will learn how to help patients effectively control pain using NSAIDs and adjunctive therapies, while protecting their GI health. Codeine unsafe for young children post-tonsillectomy New report advises strongly against using codeine for treatment of post-operative pain in young children undergoing adenotonsillectomy for sleep apnea. New risk statements required for benzocaine product labels New statements focus on the risk of methemoglobinemia and how to recognize its signs and symptoms. OTC Market Report 2012: Pain relief Pain relief options add to pharmacies’ bottom line. Do you really need that opioid? Fibromyalgia pain responds to low-dose naltrexone Custom compounded drug has ‘outstanding’ side-effect profile Rehab program tackles substance abuse, comorbid pain Mayo Clinic approach uses cognitive-behavioural therapy, exercise, other modalities Ontario College advice on managing switch from OxyContin Advisory follows fatality resulting from change in prescription from OxyContin to another opioid analgesic. Tips for self-treating minor pain Pain management is enhanced when pharmacologic therapies are combined with physical and psychological approaches. First Previous 28 29 30 31 32 Next Last
